About Lobe Sciences

Lobe Sciences is a biotechnology company focused on transforming psychedelic medicine to benefit patients of all ages. We are engaged in research and development using psychedelic and non-psychedelic compounds targeting the 5HT2A receptor. Our team is made up of biotech executives who collectively have managed the development and regulatory approval of revolutionary drugs around the globe. We plan to develop therapies that deliver high levels of efficacy yet lack the induction of a hallucinatory “trip”. We believe that treating patients at home, clinic or ED with easily administered transformational medicines is the appropriate path to creating a global pharmaceutical marketplace.